Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial91
CAR T-cell therapy comes of age: Introductory editorial for the special issue61
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation56
Clinical applications of circulating tumor DNA in Hodgkin lymphoma51
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia49
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies48
How to set up a clinical research center in Brazil, as an example of a middle-income country41
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1929
Updates on current and future research in acute myeloid leukemia25
Epidemiology and etiology of diffuse large B-cell lymphoma24
Lessons learned from the Eµ-TCL1 mouse model of CLL22
Somatic mutations in “benign” blood diseases21
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services20
The role of viruses in HIV-associated lymphomas20
TET2 mutation as prototypic clonal hematopoiesis lesion19
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence19
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future17
Antibody and immunotherapy in diffuse large B-cell lymphoma17
0.036226987838745